Cargando…
Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning
OBJECTIVE: To observe the clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning patients, and investigate the potential mechanism. METHODS: In this study, we enrolled 136 organophosphorus poisoning patients who received t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923498/ https://www.ncbi.nlm.nih.gov/pubmed/31889787 http://dx.doi.org/10.1016/j.sjbs.2019.08.010 |
_version_ | 1783481547915001856 |
---|---|
author | Jiang, Shu-zhi Ma, Bo-en Liu, Chao Wang, Rui |
author_facet | Jiang, Shu-zhi Ma, Bo-en Liu, Chao Wang, Rui |
author_sort | Jiang, Shu-zhi |
collection | PubMed |
description | OBJECTIVE: To observe the clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning patients, and investigate the potential mechanism. METHODS: In this study, we enrolled 136 organophosphorus poisoning patients who received treatment in this hospital between January 2009 and December 2017, and they were divided into three groups according to the clinical treatment methods, i.e. Group A (comprehensive treatment with HP, n = 47), Group B (continuous intravenous infusion of atropine with micropump, n = 43) and Group C (regular intravenous infusion of atropine, n = 46). In addition to the close monitoring of vital signs, we recorded the atropinization time (min), cholinesterase reactivation time (h), total dose of atropine, recurrence, incidence rate of atropine poisoning (%), hospitalization time (d) and cure rate (%). RESULTS: In comparison with Group C, patients in Group A and B manifested more stable vital signs with lower total dose of atropine and incidence rate of atropine poisoning and shorter cholinesterase reactivation time, while the cure rate was remarkably increased (p < 0.05), and no significant differences were observed in atropinization time among three groups (p > 0.05). Compared to Group B and C, total dose of atropine in Group A was significantly decreased with obvious excellence in hospitalization time, reduction of complications and increases in cure rates (p < 0.05). Moreover, patients in Group A had the lowest mortality rate among three groups. CONCLUSION: In treatment of organophosphorus poisoning patients, HP and continuous intravenous infusion of atropine using micropump can elevate the survival rate, reduce the incidence of adverse reaction, shorten the reactivation time of cholinesterase and decrease the incidence rate of complications, which are superior to the traditional treatment method. |
format | Online Article Text |
id | pubmed-6923498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-69234982019-12-30 Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning Jiang, Shu-zhi Ma, Bo-en Liu, Chao Wang, Rui Saudi J Biol Sci Article OBJECTIVE: To observe the clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning patients, and investigate the potential mechanism. METHODS: In this study, we enrolled 136 organophosphorus poisoning patients who received treatment in this hospital between January 2009 and December 2017, and they were divided into three groups according to the clinical treatment methods, i.e. Group A (comprehensive treatment with HP, n = 47), Group B (continuous intravenous infusion of atropine with micropump, n = 43) and Group C (regular intravenous infusion of atropine, n = 46). In addition to the close monitoring of vital signs, we recorded the atropinization time (min), cholinesterase reactivation time (h), total dose of atropine, recurrence, incidence rate of atropine poisoning (%), hospitalization time (d) and cure rate (%). RESULTS: In comparison with Group C, patients in Group A and B manifested more stable vital signs with lower total dose of atropine and incidence rate of atropine poisoning and shorter cholinesterase reactivation time, while the cure rate was remarkably increased (p < 0.05), and no significant differences were observed in atropinization time among three groups (p > 0.05). Compared to Group B and C, total dose of atropine in Group A was significantly decreased with obvious excellence in hospitalization time, reduction of complications and increases in cure rates (p < 0.05). Moreover, patients in Group A had the lowest mortality rate among three groups. CONCLUSION: In treatment of organophosphorus poisoning patients, HP and continuous intravenous infusion of atropine using micropump can elevate the survival rate, reduce the incidence of adverse reaction, shorten the reactivation time of cholinesterase and decrease the incidence rate of complications, which are superior to the traditional treatment method. Elsevier 2019-12 2019-08-09 /pmc/articles/PMC6923498/ /pubmed/31889787 http://dx.doi.org/10.1016/j.sjbs.2019.08.010 Text en © 2019 Production and hosting by Elsevier B.V. on behalf of King Saud University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Jiang, Shu-zhi Ma, Bo-en Liu, Chao Wang, Rui Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning |
title | Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning |
title_full | Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning |
title_fullStr | Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning |
title_full_unstemmed | Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning |
title_short | Clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning |
title_sort | clinical efficacy of intravenous infusion of atropine with micropump in combination with hemoperfusion on organophosphorus poisoning |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923498/ https://www.ncbi.nlm.nih.gov/pubmed/31889787 http://dx.doi.org/10.1016/j.sjbs.2019.08.010 |
work_keys_str_mv | AT jiangshuzhi clinicalefficacyofintravenousinfusionofatropinewithmicropumpincombinationwithhemoperfusiononorganophosphoruspoisoning AT maboen clinicalefficacyofintravenousinfusionofatropinewithmicropumpincombinationwithhemoperfusiononorganophosphoruspoisoning AT liuchao clinicalefficacyofintravenousinfusionofatropinewithmicropumpincombinationwithhemoperfusiononorganophosphoruspoisoning AT wangrui clinicalefficacyofintravenousinfusionofatropinewithmicropumpincombinationwithhemoperfusiononorganophosphoruspoisoning |